Jaffetilchin Investment Partners, LLC Eli Lilly & CO Transaction History

Jaffetilchin Investment Partners, LLC

$1.49 Billion
Q2 2025

A detailed history of Jaffetilchin Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 17,335 shares of LLY stock, worth $13.9 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

17,335

Previous 14,987 15.67%

Holding current value

$13.9 Million

Previous $12.4 Million 9.18%

% of portfolio

0.9%

Previous 0.92%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$713.71 - $898.95 $1.68 Million - $2.11 Million	2,348 Added 15.67%	17,335 $13.5 Million
Q1 2025 Apr 24, 2025	BUY	$725.72 - $929.72 $74,023 - $94,831	102 Added 0.69%	14,987 $12.4 Million
Q4 2024 Feb 13, 2025	BUY	$727.2 - $932.06 $194,889 - $249,792	268 Added 1.83%	14,885 $11.5 Million
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $535,093 - $665,293	693 Added 4.98%	14,617 $12.9 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $125,402 - $157,263	173 Added 1.26%	13,924 $12.6 Million
Q1 2024 May 16, 2024	BUY	$592.2 - $792.28 $224,443 - $300,274	379 Added 2.83%	13,751 $10.7 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $262,069 - $308,945	-499 Reduced 3.6%	13,372 $7.79 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $91,287 - $125,852	210 Added 1.54%	13,871 $7.45 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $239,906 - $320,782	-684 Reduced 4.77%	13,661 $6.41 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $353,496 - $415,165	1,138 Added 8.62%	14,345 $4.93 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $70,097 - $81,678	-218 Reduced 1.62%	13,207 $4.83 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $147,647 - $168,259	498 Added 3.85%	13,425 $4.34 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $150,514 - $176,725	540 Added 4.36%	12,927 $4.19 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $438,400 - $544,820	1,868 Added 17.76%	12,387 $3.61 Million
Q4 2021 Feb 17, 2022	SELL	$224.85 - $279.04 $174,933 - $217,093	-778 Reduced 6.89%	10,519 $2.91 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $1.53 Million - $1.88 Million	-6,911 Reduced 37.96%	11,297 $2.61 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $1.66 Million - $2.15 Million	9,206 Added 102.27%	18,208 $3.75 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $310,564 - $402,040	1,890 Added 26.57%	9,002 $1.68 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $401,164 - $530,837	3,075 Added 76.17%	7,112 $1.2 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $271,384 - $313,905	1,856 Added 85.1%	4,037 $598,000
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $295,622 - $355,778	2,167 Added 15478.57%	2,181 $358,000
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $345,551 - $415,867	-2,533 Reduced 99.45%	14 $358,000
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $72,263 - $89,441	607 Added 31.29%	2,547 $353,000
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $6,842 - $8,475	-64 Reduced 3.19%	1,940 $255,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $17,193 - $18,701	-161 Reduced 7.44%	2,004 $224,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $110,346 - $128,802	-996 Reduced 31.51%	2,165 $240,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $110,530 - $130,102	-993 Reduced 23.9%	3,161 $410,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $177,806 - $199,196	1,679 Added 67.84%	4,154 $481,000
Q3 2018 Oct 05, 2018	BUY	$85.86 - $107.31 $212,503 - $265,592	2,475 New	2,475 $266,000
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $870,858 - $934,094	-10,628 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $819,099 - $909,119	10,628	10,628 $909,000

Others Institutions Holding LLY

# of Institutions

4,449

Shares Held

781M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.

Account

Jaffetilchin Investment Partners, LLC Eli Lilly & CO Transaction History